Nanoparticles as carriers for nasal vaccine delivery
Explore this paper's citation graph
Summary
The goal of the present article is to review the recent advances in the design of polymeric nanosystems intended to be used as carriers for nasal vaccine delivery and present nanocarriers that have been made of safe materials, such as biodegradable polyesters and polysaccharides.
- Type
- review
- Published
- 2005-04-01
- Cited by
- 129
- References
- 74
- OpenAlex
- https://openalex.org/W1982431512
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:20471116
Keywords
Nanocarriers, Immune system, Antigen, Nanotechnology, Immunology
References
- Microparticles for intranasal immunization.
- PLA-PEG particles as nasal protein carriers: the influence of the particle size.
- The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
- A Novel System Based on a Poloxamer/ PLGA Blend as a Tetanus Toxoid Delivery Vehicle
- Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
- Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
- Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice
- Development of Systems for Targeting the Regional Lymph Nodes for Diagnostic Imaging: In Vivo Behaviour of Colloidal PEG-Coated Magnetite Nanospheres in the Rat Following Interstitial Administration
- Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
- Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
- Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
- Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
- Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
- Recent Advances in Vaccine Adjuvants
- Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.
- Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.
- Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
- Immunostimulating complexes (ISCOMs) for nasal vaccination.
- Immune responses to ISCOM formulations in animal and primate models.
- The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
Cited by
- Quantifying drug release from PLGA nanoparticulates.
- DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases
- Élaboration d'assemblages colloïdaux à partir de nanoparticules de poly(acide lactique) et de chitosane
- In vivo efficacy and toxicity evaluation of polycaprolactone nanoparticles and aluminum based admixture formulation as vaccine delivery system.
- Factors involved in the design of nasal delivery systems for peptides and proteins
- Controlled release matrices and micro/nanoparticles of chitosan with antimicrobial potential: development of new strategies for microbial control in agriculture.
- Applications of Nanotechnology in Vaccine Delivery
- Ciencia y salud global: la brecha del desarrollo
- In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles
- Mucoadhesive drug delivery systems (Review)
- Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases
- Evaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacy.
- Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally.
- Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
- Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental design
- Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
- Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
- Particle assemblies: toward new tools for regenerative medicine.
- Nanomedicine: novel approaches in human and veterinary therapeutics.
- Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants.
Related papers
- The emergence of nanocarriers in the management of diseases and disorders
- Delivery of Doxorubicin Using Double-Layered Core-Shell Nanocarrier Based on Magnetic Fe3O4 Core and Salep Shells.
- General justification in terms of effectiveness and toxicities for the use of nanocarriers
- An Analysis of the Capturing and Passing Ability of a DNA Origami Nanocarrier with the Aid of Molecular Dynamics Simulation
- Aspherical and Spherical InvA497-Functionalized Nanocarriers for Intracellular Delivery of Anti-Infective Agents
- Protein Corona on Brain Targeted Nanocarriers: Challenges and Prospects.
- Targeted adhesion of dendrimer nanocarriers to hypoxia-injured primary cardiomyocyte cultures
- Nanoparticle-mediated Drug Delivery Systems (DDS) in the Central Nervous System
- pH-responsive anticancer drug delivery systems: Insights into the enhanced adsorption and release of DOX drugs using graphene oxide as a nanocarrier